Orexin-a elevation in antipsychotic-treated compared to drug-free patients with schizophrenia: A medication effect independent of metabolic syndrome

Orexin-a elevation in antipsychotic-treated compared to drug-free patients with schizophrenia: A medication effect independent of metabolic syndrome

Background/Purpose: Orexin-A levels are reportedly increased in antipsychotic (APD)-treated patients with schizophrenia compared to healthy controls and have been associated with metabolic abnormalities. It is not clear whether the orexin-A elevation is related specifically to the drug (APDs) effect...

Full description

Bibliographic Details
Main Authors: Po-Yu Chen, Chin-Kuo Chang, Chun-Hsin Chen, Su-Chen Fang, Valeria Mondelli, Chih-Chiang Chiu, Mong-Liang Lu, Ling-Ling Hwang, Ming-Chyi Huang
Format: Article
Language:English
Published: Elsevier 2022-11-01
Series:Journal of the Formosan Medical Association
Subjects:
Orexin-A
Schizophrenia
Antipsychotics
Metabolic syndrome
Type 2 diabetes mellitus
Online Access:http://www.sciencedirect.com/science/article/pii/S0929664622001103

Internet

http://www.sciencedirect.com/science/article/pii/S0929664622001103

Similar Items